Low TLR9 expression defines an aggressive subtype of triple-negative breast cancer (Q39305431)

10 September 2017

Low TLR9 expression defines an aggressive subtype of triple-negative breast cancer (English)

1 reference

10 September 2017

0 references

14

Ylermi Soini

1 reference

10 September 2017

Arja Jukkola-Vuorinen

15

object named as

Arja Jukkola-Vuorinen

1 reference

10 September 2017

Johanna Tuomela

1

1 reference

10 September 2017

Jouko Sandholm

2

1 reference

10 September 2017

Peeter Karihtala

3

1 reference

10 September 2017

Joanna Ilvesaro

4

1 reference

10 September 2017

Katri S Vuopala

5

1 reference

10 September 2017

Joonas H Kauppila

6

1 reference

10 September 2017

Saila Kauppila

7

1 reference

10 September 2017

Dongquan Chen

8

1 reference

10 September 2017

Christine Pressey

9

1 reference

10 September 2017

Pirkko Härkönen

10

1 reference

10 September 2017

Kevin W Harris

11

1 reference

10 September 2017

David Graves

12

1 reference

10 September 2017

Päivi K Auvinen

13

1 reference

10 September 2017

Katri S Selander

16

1 reference

10 September 2017

language of work or name

English

0 references

publication date

31 July 2012

1 reference

Breast Cancer Research and Treatment

10 September 2017

1 reference

10 September 2017

135

1 reference

10 September 2017

2

1 reference

10 September 2017

481-493

1 reference

https://scigraph.springernature.com/pub.10.1007/s10549-012-2181-7

10 September 2017

0 references

cites work

Recognition of pathogen-associated molecular patterns by TLR family

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2181-7

The immunobiology of the TLR9 subfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2181-7

A novel Toll-like receptor that recognizes vesicular stomatitis virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2181-7

Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2181-7

Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2181-7

TLR9 is localized in the endoplasmic reticulum prior to stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2181-7

Ligand-regulated chimeric receptor approach reveals distinctive subcellular localization and signaling properties of the Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2181-7

Expression and subcellular distribution of toll-like receptors TLR4, TLR5 and TLR9 on the gastric epithelium in Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2181-7

Toll like receptor-9 agonists stimulate prostate cancer invasion in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2181-7

Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2181-7

Human lung cancer cells express functionally active Toll-like receptor 9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2181-7

TLR9 signaling promotes tumor progression of human lung cancer cell in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2181-7

Toll-like receptor 9 mediates CpG oligonucleotide-induced cellular invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2181-7

Toll-like receptor-9 expression is inversely correlated with estrogen receptor status in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2181-7

Toll-like receptor 9 expression in breast and ovarian cancer is associated with poorly differentiated tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2181-7

Toll-like receptor 9 is a novel biomarker for esophageal squamous cell dysplasia and squamous cell carcinoma progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2181-7

Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2181-7

Role of hypoxia in the hallmarks of human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2181-7

Visualization of hypoxia in microscopic tumors by immunofluorescent microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2181-7

The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2181-7

BRCA1 tumours correlate with a HIF-1alpha phenotype and have a poor prognosis through modulation of hydroxylase enzyme profile expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2181-7

Hypoxia inducible factor (HIF)-1 coordinates induction of Toll-like receptors TLR2 and TLR6 during hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2181-7

Beyond oxygen: complex regulation and activity of hypoxia inducible factors in pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2181-7

Hypoxia stimulates breast carcinoma cell invasion through MT1-MMP and MMP-2 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2181-7

Chloroquine and inhibition of Toll-like receptor 9 protect from sepsis-induced acute kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2181-7

Absent Toll-like receptor-9 expression predicts poor prognosis in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2181-7

Estrogen receptor-α and sex steroid hormones regulate Toll-like receptor-9 expression and invasive function in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2181-7

The functional effects of physical interactions among Toll-like receptors 7, 8, and 9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2181-7

Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2181-7

IGF-1 induced HIF-1α-TLR9 cross talk regulates inflammatory responses in glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2181-7

Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2181-7

Hypoxia-inducible factor-1alpha is a key regulator of metastasis in a transgenic model of cancer initiation and progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2181-7

Hypoxia-inducible factor-1 in human breast and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2181-7

aHIF but not HIF-1α transcript is a poor prognostic marker in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2181-7

Triple-Negative Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2181-7

A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2181-7

Apoptosis in toremifene-induced growth inhibition of human breast cancer cells in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2181-7

Interlaboratory comparison of HER-2 oncogene amplification as detected by chromogenic and fluorescence in situ hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2181-7

10.1007/S10549-012-2181-7

21 January 2018

Identifiers

DOI

1 reference

10 September 2017

1 reference